The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome suggested that risk-reducing total hysterectomy and BSO should be offered no earlier than 35–40 years of age, following completion of childbearing, to path_MLH1, path_MSH2 and path_MSH6 carriers. The gene discussed is MSH2; the disease is female reproductive organ cancer.